Rocket Doctor AI (AIRDF) Stock Analysis & Winston Score
Rocket Doctor AI (formerly Rocket Doctor) is a Canadian telehealth company that connects patients with doctors through virtual visits using phones, tablets, or computers. It serves individuals and employers who want convenient access to healthcare without visiting a clinic in person. The company has been integrating artificial intelligence tools to help streamline medical consultations and administrative tasks. Rocket Doctor generates revenue primarily through fees for virtual medical appointments and enterprise contracts with employers and organizations. It operates mainly in Canada and is a very small company by market capitalization, still in an early stage of growth. Its deeply negative operating margins reflect heavy spending relative to modest revenues as it tries to build scale. The key risk is whether the company can grow its user base fast enough to reach profitability before needing additional capital, especially in an increasingly competitive telehealth market.
Winston Score: 24/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Mixed (7/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.45
Market Cap: $44M
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Exchange: Other OTC
